Key Highlights

● Each right converts into one-fifth of a Class A share.

● Five rights are needed to receive one whole share.

● The 17,250,000 public rights would convert into 3,450,000 shares.

● Rights would ordinarily expire worthless if the deadline passes without a deal.

AACPR is the Nasdaq ticker for the rights issued by Apogee Acquisition Corp (NASDAQ:AACPR), a Cayman Islands blank-cheque company. A right is not a share and not a warrant. Under the terms disclosed in the company's prospectus and closing filing, each right entitles its holder to receive one-fifth of one Class A ordinary share when the company completes an initial business combination.

The rights began life as one component of the company's units, which were priced at US$10.00 on 6 April 2026. Each unit contained one Class A ordinary share, one redeemable warrant and one right. After the over-allotment option was exercised in full, the company closed an offering of 17,250,000 units on 8 April 2026, raising US$172.5 million before costs.

How the Conversion Mechanics Work

Because each right converts into a fifth of a share, five rights are needed to receive one whole Class A share. The disclosures describe no exercise price for the conversion, and the right is not a share, so it is not described as carrying voting or dividend entitlements beforehand. Its value depends entirely on a transaction closing.

The sponsor, Apogee Acquisition Sponsor LLC, also bought 470,000 private placement units for US$4.7 million. Those units carry their own rights, which helps explain why the company reported 17,720,000 Class A shares outstanding at 20 August 2026 alongside 5,750,000 Class B founder shares.

The Trust and the Deadline

The rights sit within a structure backed by a trust account of US$173,362,500, or US$10.05 per public share, held with Efficiency INC. as trustee. Public shareholders, not rights holders, have redemption claims on that cash. By 30 June 2026 the trust had grown to US$174,798,579, reflecting investment income of US$1,436,079, according to the quarterly report.

The company must finish a deal by 8 July 2027, which is 15 months after closing, and the filing says no extension has been approved. Management also disclosed substantial doubt about going concern because of the liquidation timetable. If the deadline passes without a transaction, rights in a SPAC of this kind would ordinarily expire worthless.

Accounting and Dilution

The company classifies its rights, like its public and private warrants, as equity under US accounting rules, so they are not remeasured each quarter. For existing holders, the practical effect is dilution: the 17,250,000 public rights would convert into 3,450,000 Class A shares if all were outstanding at completion, and the private placement units would add a further 94,000 shares. Those figures are arithmetic from the disclosed ratio, not reported estimates.

Founder shares, warrants and any shares issued to a target's owners would add further dilution, which is why the net effect on a combined company depends on deal terms that do not yet exist.

Rights Pay Off Only if Apogee Closes a Deal

No target has been named. The company says it will focus on advanced technology across physical and digital domains, though its search is open. Without a merger agreement, there is no valuation, financing structure or closing date to analyse. The latest financial statements cover the quarter ended 30 June 2026 and are unaudited.

Rights have no stated link to the trust per-share amount, so their worth depends on the market's view of a future merged business, not on cash held in the account today.

Upcoming events to monitor include a definitive agreement, the next Form 10-Q and any shareholder vote on extension.